These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 9470240)

  • 1. [Prevention of cardiovascular risk in menopause women: role of ovarian hormones].
    Rosano GM; Leonardo F; Ricci S; Serra GB; Chierchia SL
    Ann Ist Super Sanita; 1997; 33(2):199-202. PubMed ID: 9470240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cardiovascular risk factors and prevention in women: similarities and differences].
    Sclavo M
    Ital Heart J Suppl; 2001 Feb; 2(2):125-41. PubMed ID: 11255880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Noncontraceptive estrogen use and cardiovascular disease.
    Bush TL; Barrett-Connor E
    Epidemiol Rev; 1985; 7():89-104. PubMed ID: 2996919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative cardiovascular effects of different progestins in menopause.
    Rosano GM; Fini M
    Int J Fertil Womens Med; 2001; 46(5):248-56. PubMed ID: 11720197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hormone replacement therapy and cardiovascular risk].
    Maffei S; De Caterina R
    G Ital Cardiol; 1996 Aug; 26(8):899-940. PubMed ID: 9005173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oestrogens and the heart.
    Rosano GM; Panina G
    Therapie; 1999; 54(3):381-5. PubMed ID: 10500455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can menopause be considered an independent risk factor for cardiovascular disease?
    Mercuro G; Zoncu S; Cherchi A; Rosano GM
    Ital Heart J; 2001 Oct; 2(10):719-27. PubMed ID: 11721715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hormone replacement therapy and cardioprotection: what is good and what is bad for the cardiovascular system?
    Rosano GM; Vitale C; Fini M
    Ann N Y Acad Sci; 2006 Dec; 1092():341-8. PubMed ID: 17308159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cardiovascular physiopathology of ovarian hormones].
    de Ziegler D
    Praxis (Bern 1994); 1997 Jan; 86(5):138-44. PubMed ID: 9064731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sex hormones and the cardiovascular system: effects on arterial function in women.
    Teede HJ
    Clin Exp Pharmacol Physiol; 2007 Jul; 34(7):672-6. PubMed ID: 17581228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Role of hormone replacement therapy during menopause in the cardiovascular prevention].
    Turpin G
    Ann Cardiol Angeiol (Paris); 1994 Mar; 43(3):177-80. PubMed ID: 8024230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular protection by estrogen: a hemodynamic mechanism?
    Rozenberg S; Liebens I; Vandromme J; Hotimsky A; Van Rijsselberge M
    Int J Fertil Menopausal Stud; 1994; 39 Suppl 1():36-42. PubMed ID: 8199639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hormone replacement therapy and the cardiovascular system lessons learned and unanswered questions.
    Ouyang P; Michos ED; Karas RH
    J Am Coll Cardiol; 2006 May; 47(9):1741-53. PubMed ID: 16682298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Natural estrogens and the cardiovascular system].
    Bader A; Sacrez J; Langer B; Sacrez A
    J Gynecol Obstet Biol Reprod (Paris); 1996; 25(3):233-7. PubMed ID: 8767217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Should all menopausal women have hormone replacement therapy for the prevention of coronary disease?].
    Neves-e-Castro M
    Rev Port Cardiol; 1999 Nov; 18(11):1039-43. PubMed ID: 10608164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hormone replacement therapy and cardiovascular risk in postmenopausal women].
    Kovacev-Zavisić B; Icin T; Kovacev N
    Med Pregl; 2009; 62 Suppl 3():85-90. PubMed ID: 19702123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hormones and cardiovascular health in women.
    ESHRE Capri Workshop Group
    Hum Reprod Update; 2006; 12(5):483-97. PubMed ID: 16807276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The case for a nonplasma lipoprotein etiology of reduced vascular risk in estrogen replacement therapy.
    de Lignieres B
    Curr Opin Obstet Gynecol; 1993 Jun; 5(3):389-95. PubMed ID: 8329655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Estrogens and lipid metabolism].
    Berthezène F
    Therapie; 1999; 54(3):393-5. PubMed ID: 10500457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exercise training associated with estrogen therapy induced cardiovascular benefits after ovarian hormones deprivation.
    Flues K; Paulini J; Brito S; Sanches IC; Consolim-Colombo F; Irigoyen MC; De Angelis K
    Maturitas; 2010 Mar; 65(3):267-71. PubMed ID: 20004069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.